Updates

Eagle Eye - Moves to EBITDA profitability

August 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Eagle Eye has issued a trading update for the year to end June, with sales up 23% to £16.9m and making the long-awaited breakthrough into ebitda profits (£0.7m versus ebitda loss of £2m last year). With £0.6m cash generated in H2, it ended the year with net debt of £1.2m. Revenue generated by the AIR platform grew 32% to represent 94% (2018: 88%) of total revenue for the period. This has been driven by growth in redemption and interactions were 847m for the period, a 110% increase from 404m and was driven by Loblaw, although the period also saw higher one-off implementation fees with larger clients. Overall recurring revenue from subscription fees and transactions was 71% of the total. Await r ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Swallowfield - Sale of division leaves 150p cash per share

Scientific Digital Imaging

Eagle Eye (February 2023)

Eagle Eye - Wins further North American business (March 2022)

Eagle Eye (April 2021)

Eagle Eye (October 2020)

Eagle Eye (December 2019)

Eagle Eye - Shares well off the 316p high; 72% recurring fees (June 2019)

Eagle Eye - Positive EBITDA expected for H2 (April 2019)

Eagle Eye (December 2018)

Eagle Eye (August 2017)

Eagle Eye (July 2017)

Eagle Eye - Strong momentum with tier 1 retailers continues (June 2017)

Eagle Eye - Coupon redemption volumes rise to 4m a month in February (May 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X